India Glycols share price, P/E, ROE & financials

As of 6 Nov 2026, India Glycols trades at 6.0× trailing earnings, below the industry P/E of 18.2×, and the shares are 76% below their 52-week high. Sales and net profit grew 17% and 33% a year over 3 years, with ROCE of 12% and ROE of 11%. Debt is 0.58× equity, and its dividend yield is 2.5%. It is a small-cap company with a market cap of ₹1,974 Cr, ranked 16th of 76 Chemicals companies by market cap; the shares fell 69% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹307.10
Day high: ₹308.55
Day low: ₹289.65
Prev. close: ₹311.15
Volume: 7.2 L

Health check

2 good · 2 fair · 2 to check

ReturnsBehind
−69.3% over a year, better than 0 of 7 peers.
Price tagCheaper
P/E 6.0 vs industry 18.2.
GrowthStrong
Sales +17.3%, profit +32.8% a year over 3 years.
ProfitabilityAverage
ROCE 11.7% vs peer median 10.6%.
Balance sheetFair
Debt 0.58× equity, interest covered 3.5×, Piotroski 5 of 9.
Red flags1 to check
76% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Chemicals

75 listed peers. Screen the industry

Small cap

₹1,974 Cr, #16 of 76 in its industry by size.

Defensive

Beta 0.31 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹4,301 Cr · profit ₹316 Cr

Market cap: ₹1,974 Cr; Small cap
P/E: 6.0; Industry 18.2
Price to book: 0.67; Peers 2.62
Dividend yield: 2.55%
ROE: 11.3%; Peers 11.7%
ROCE: 11.7%; Peers 10.6%
Debt to equity: 0.58; Debt ₹1,691 Cr
EPS (TTM): ₹49.39; Face value ₹5
OPM (TTM): 17.3%; Net margin 7.4%
Sales growth: +8.6%; Latest quarter vs a year ago
Profit growth: +32.2%; Latest quarter vs a year ago
Price to sales: 0.46; EV/EBITDA 5.6

Strengths

Dividend yield of 2.55%.
Quarterly profit up 32.2% on a year ago.
P/E of 6.0 against an industry P/E of 18.2.
Positive operating cash flow in each of the last 4 years.

Risks to check

76% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About India Glycols

India Glycols Limited manufactures and sells bio-based specialities and performance chemicals in India and internationally. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, Ennature Biopharma, and Bio-Fuel segments. The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethylene and diethylene glycol monoethyl ethers, ethylene and diethylene glycol monoethyl ether acetates, and brake fluids;…

Headquarters: Noida
Employees: 1,400
Sector: Basic Materials
ISIN: INE560A01023
Website: indiaglycols.com

Price range

52 weeks

₹217.00₹1,222.00

Today

₹289.65₹308.55

Avg volume (3M): 11.9 L
1-year return: minus 69.3%
From 52-week high: minus 75.9%

Peers · Chemicals

Capital-heavy industry columns

Compare with peers Screen the whole industry

Company
NAVINFLUORNavin Fluorine International	9,010.00	plus 1.87%	46,250	50.8	42.7	18.7%	34.3%	0.28	16.5%	plus 46.1%
DEEPAKNTRDeepak Nitrite	1,533.60	minus 0.67%	20,917	19.7	22.3	10.8%	18.0%	0.27	−0.5%	minus 11.9%
TATACHEMTata Chemicals	607.45	minus 1.36%	15,475	–	12.4	−3.0%	12.2%	0.36	−4.8%	minus 31.0%
DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp.	1,155.30	minus 0.69%	14,599	14.8	11.5	11.2%	17.6%	0.76	2.6%	minus 22.7%
RPELRaghav Productivity Enhancers	1,780.80	plus 0.95%	8,178	116.0	107.1	–	29.9%	0.02	23.5%	plus 95.4%
GNFCGujarat Narmada Valley Fertilizers and Chemicals	451.80	minus 1.87%	6,639	6.3	5.4	10.4%	14.8%	0.01	−8.8%	minus 7.2%
ACIArchean Chemical Industries	416.40	minus 1.95%	5,141	51.3	23.2	7.7%	20.0%	0.28	−9.2%	minus 34.6%
INDIAGLYCOIndia Glycols	294.55	minus 5.34%	1,974	6.0	5.4	11.7%	11.2%	0.58	17.3%	minus 69.3%
Median of 7 peers	–	−0.69%	14,599	35.2	22.3	10.6%	18.0%	0.28	−0.5%	−11.9%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
1,040	1,092	1,102	976	1,130
891	935	927	810	888
150	158	175	167	243
14.4%	14.4%	15.9%	17.1%	21.5%
20	13.7	4	13.6	21
44.7	49.3	46.8	26.4	25.2
34.5	38.5	41.2	41.2	115
–	–	−0.8	–	–
90.5	83.6	90.6	112	123
19.1%	22.2%	25.4%	22.7%	21.2%
73.3	65.1	67.6	86.9	96.8
23.66	10.51	10.79	13.64	14.45

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +17.3%
Profit CAGR 3Y: +32.8%
EPS CAGR 3Y: +26.4%
ROE: 11.3%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
2,577	3,294	3,694	4,158
–	+27.8%	+12.2%	+12.6%
2,249	2,874	3,141	3,495
328	420	553	663
12.7%	12.7%	15.0%	15.9%
−13.6	6	−8.1	20.1
85	105	138	151
94	101	115	155
29.7	3.3	1	0.4
165	223	292	377
14.5%	22.5%	21.0%	22.4%
125	173	231	293
–	+38.3%	+33.5%	+26.8%
22.77	27.93	37.29	45.95

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
31	31	31	33.5
1,870	2,020	2,225	2,899
1,112	1,348	1,892	1,691
1,845	2,218	2,029	1,900
4,858	5,617	6,176	6,523
2,838	3,284	3,928	4,590
130	87.5	102	39
44.3	42.5	44.2	41.1
47.7	74.6	131	71.2
1,798	2,128	1,971	1,781
4,858	5,617	6,176	6,523

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
326	439	362	769
−330	−503	−736	−767
−0.5	89.9	354	22.5
−5.1	25	−20.1	25
−439	−553	−760	−823
−113	−114	−398	−54.3
−23	−23	−24.6	−75.3

Shareholding pattern

Source: NSE filings

59.6%

promoters

Promoters59.63%
Public40.37%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	59.63%	40.37%	0.00
30 Jun 2026	59.63%	40.37%	0.00
31 Mar 2026	59.63%	40.37%	0.00
31 Dec 2025	59.63%	40.37%	0.00
24 Nov 2025	59.63%	40.37%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you